Between shifting compliance guidelines, legislative budget cuts, and a deepening workforce crisis, early 2026 is proving to be a volatile time for healthcare policy. For medical practices, billing companies, and healthcare executives, staying ahead of federal changes is no longer optional—it is a financial necessity.
Based on recent intelligence out of Washington, including the latest Congressional Budget Office (CBO) projections and HHS reports, here are the five major policy trends you need to monitor right now.
1. The Unintended Consequences of the No Surprises Act (NSA)
When the NSA was enacted, the primary goal was patient protection. A secondary goal was to drive more providers in-network. However, new data from the Government Accountability Office (GAO) indicates that the law’s Independent Dispute Resolution (IDR) process might be having unintended consequences.
While network participation has seen modest bumps in specialties like Emergency Medicine and Air Ambulance, the IDR arbitration does create financial challenges and potential imbalances. Providers are winning upwards of 80% of disputes and IDR awards frequently outpace the median in-network rates offered by health plans because of a concentrated group of companies that seek exorbitant awards. As a result, some critics argue the system inadvertently incentivizes providers to remain out-of-network. With a massive concentration of disputes tied up by just four companies across the nation, health plans are likely to lobby Congress for reforms that tip the scales back in their favor.
At Kovo RCM, we have deep experience with the IDR process and treat IDR as a tool for revenue protection, rather than a method for unfair profit extortion from payers. Integrity is one of our core values and we stand by it. We share concerns that there are four major companies which contribute to requests that far exceed the market; these exorbitant requests may make it more difficult for responsible physicians to participate. We support guardrails in the process to allow those that use it in good faith to continue to seek equitable reimbursement for out-of-network anesthesia and air ambulance providers.
Good Read! 👉 Why More Healthcare Practices Are Choosing Kovo RCM: A Partner You Can Count On
2. The Workforce Paradox: Job Growth vs. Physician Burnout
Healthcare remains the undisputed heavyweight champion of the U.S. labor market, driving nearly two-thirds of all new jobs created in January. Yet, this economic dominance masks a severe internal crisis.
During a recent Senate Aging Committee hearing, witnesses painted a grim picture of a mass exodus looming over the medical field. The root of the burnout isn’t just clinical fatigue; it’s administrative suffocation. Regulatory mandates, complex insurance compliance, and a volume-driven profit model are stripping doctors of their ability to practice medicine as trained. The crisis is particularly devastating in rural areas, where staffing shortages force physicians into dual roles as clinicians and practice managers. Without aggressive administrative simplification—such as the proposed Improving Seniors Timely Access to Care Act—the industry faces an unsustainable brain drain.
3. Federal Deficit Reduction and the Medicaid Squeeze
The fiscal outlook for federal healthcare spending is tightening. The CBO’s latest 10-year outlook projects that mandatory outlays for major health programs will skyrocket from $1.9 trillion this year to $3.1 trillion by 2036, largely driven by an aging population and rising Medicare costs.
To offset this, lawmakers are targeting Medicaid. The recently debated One Big Beautiful Bill Act (OBBBA) is projected to slash the federal deficit by $1 trillion over the next decade, with the lion’s share of those savings pulled directly from Medicaid spending reductions. For providers heavily reliant on Medicaid populations, these impending funding cuts will likely translate into tighter operational margins and even thinner staffing capabilities.
4. A New Era of Medicare Advantage (MA) Fraud Oversight
Healthcare fraud costs Medicare and Medicaid an estimated $100 billion annually, and bad actors are getting highly sophisticated. A recent House Energy and Commerce Committee hearing highlighted the alarming rise of artificial intelligence (AI) being used to fabricate electronic health records, alongside growing vulnerabilities in telehealth billing and Medicare Advantage risk score manipulation.
In response, the HHS Office of Inspector General (OIG) has launched its new Medicare Advantage Industry Segment-Specific Compliance Program Guidance (ICPG). While currently voluntary, this framework sets a new baseline for how organizations must manage compliance risks regarding network adequacy, marketing, and accurate claims submission. If you operate within the MA space, auditing your internal compliance against this new ICPG should be a top priority this quarter.
5. Direct-to-Consumer Pharma: The “TrumpRx” Launch
In a significant shift for prescription drug access, the White House has officially rolled out the “TrumpRx” portal. Building on ongoing federal drug price negotiations, the site allows consumers to bypass their insurance and purchase about 40 brand-name medications directly from manufacturers at steep discounts. Notably, the site features highly sought-after GLP-1 weight-loss drugs for $149–$350 per dose and caps insulin at $25. While this offers immediate financial relief for cash-pay patients, practices should remind patients that these out-of-pocket purchases will not be applied toward their insurance deductibles or out-of-pocket maximums.
Good Read! 👉 The 2026 Medicare Extenders: What the New Federal Legislation Means for Your Practice
Looking Forward
The convergence of Medicaid funding pressure, Medicare Advantage oversight, IDR reforms, and workforce challenges means 2026 will be a defining year for healthcare organizations. Providers who prioritize compliance, streamline administrative processes, and partner with experienced revenue cycle experts will be best positioned to protect revenue and maintain operational stability. At Kovo RCM, we monitor these federal policy shifts closely so our clients can focus on patient care with confidence, knowing their revenue cycle is strategically managed in a complex and evolving landscape.
Need expert guidance on navigating 2026’s shifting healthcare policies? Schedule a free consultation with Kovo RCM to ensure your revenue cycle and operations are prepared to thrive in a challenging regulatory landscape.
Schedule a Consultation with us Today!
